10.1002/ejoc.201601484
European Journal of Organic Chemistry
FULL PAPER
Colorless solid (41.6 mg, 71%); mp 149-151 0C; 1H NMR (500 MHz, CDCl3)
δ = 7.55 (t, J = 7.5 Hz, 4H), 7.43 (dd, J = 8.0, 7.5 Hz, 5H), 7.32 (t, J = 7.5 Hz,
1H), 6.48 (s, 1H), 6.47 (d, J = 3.5 Hz, 1H), 6.39 (dd, J = 7.0, 8.5 Hz, 1H), 5.18
(s, 2H); 13C NMR (126 MHz, CDCl3) δ = 152.93, 149.51, 143.38, 140.46,
136.92, 136.52, 128.75, 127.70, 127.02, 126.78, 118.95, 110.81, 110.64,
58.76; HRMS (ESI-TOF): [M + H]+ calculated for C18H16NO3+: 294.1125, found:
294.1130.
126.29, 126.05, 125.82, 125.21, 120.56, 52.63. Two carbons are not visible
due to overlapping peaks; [M + H]+ calculated for C12H12NO2+: 201.0863,
found: 201.0867.
General Procedure for the Preparation of 3 (3a as Example). To a
solution of 4-isocyanobiphenyl 1a (0.2 mmol, 35.8 mg) and ethyl diazoacetate
(0.2 mmol, 0.021 mL) in diethylamine (2.0 mL) was added Rh(PPh3)3Cl (0.01
mmol, 9.2 mg). The reaction mixture was stirred at 60 0C for 1 hour. After 1a
was consumed (monitored by TLC), the reaction mixture was poured into
water (50 mL) and extracted with CH2Cl2 (10 mL × 3). The combined organic
extracts were dried over anhydrous Na2SO4, filtered and concentrated under
reduced pressure to yield the corresponding crude product, which was purified
by chromatography (silica gel, petroleum ether/acetone = 5/1, V/V) to give 3a.
Cyclohexyl [1,1'-biphenyl]-4-ylcarbamate (2l)
Colorless solid (38.4 mg, 65%); mp 155-157 0C; 1H NMR (500 MHz, CDCl3)
δ = 7.57-7.53 (m, 4H), 7.46-7.40 (m, 4H), 7.32 (t, J = 7.5 Hz, 1H), 6.64 (s, 1H),
4.79-4.76 (m, 1H), 1.96-1.95 (m, 2H), 1.78-1.76 (m, 2H), 1.59-1.56 (m, 1H),
1.52-1.38 (m, 4H), 1.32-1.27 (m, 1H); 13C NMR (126 MHz, CDCl3) δ = 153.14,
140.56, 137.44, 136.09, 128.72, 127.63, 126.74, 118.83, 73.73, 31.92, 25.37,
23.78. One carbon is not visible due to overlapping peaks; HRMS (ESI-TOF):
[M + H]+ calculated for C19H22NO2+: 296.1645, found: 296.1651.
3-([1,1'-Biphenyl]-4-yl)-1,1-diethylurea (3a)
Yellow liquid (43.4 mg, 81%); 1H NMR (500 MHz, CDCl3) δ = 7.60-7.58 (m,
3H), 7.52-7.50 (m, 2H), 7.41 (t, J = 9.5 Hz, 2H), 7.29 (t, J = 8.0 Hz, 1H), 7.03
Isopropyl [1,1'-biphenyl]-4-ylcarbamate (2m)
Colorless solid (37.2 mg, 73%); mp 161-163 0C; 1H NMR (500 MHz, CDCl3)
δ = 7.55 (t, J = 8.5 Hz, 4H), 7.47-7.40 (m, 4H), 7.32 (t, J = 7.5 Hz, 1H), 6.71 (s,
1H), 5.01-5.06 (m, 1H), 1.32 (d, J = 6.5 Hz, 6H); 13C NMR (126 MHz, CDCl3) δ
= 153.18, 140.53, 137.39, 136.10, 128.71, 127.61, 126.73, 118.64, 68.80,
22.08. One carbon is not visible due to overlapping peaks; HRMS (ESI-TOF):
[M + Na]+ calculated for C16H17NNaO2+: 278.1151, found: 278.1148.
(q, J = 2.5, 6.0 Hz, 2H), 3.51 (s, 2H), 3.33 (s, 2H), 1.23 (t, J = 9.0 Hz, 6H); 13
C
NMR (126 MHz, CDCl3) δ = 152.19, 141.08, 135.18, 130.84, 128.58, 127. 61,
126.60, 126.46, 121.35, 45.71, 39.53, 14.98, 12.43; HRMS (ESI-TOF): [M +
H]+ calculated for C17H21N2O+: 269.1648, found: 269.1645.
N-([1,1'-Biphenyl]-4-yl)piperidine-1-carboxamide (3b)
Yellow liquid (53.2 mg, 95%); 1H NMR (500 MHz, CDCl3) δ = 7.61-7.57 (m,
3H), 7.53 (d, J = 8.5 Hz, 2H), 7.42 (t, J = 8.0 Hz, 2H), 7.31 (t, J = 1.5 Hz, 1H),
7.30-7.04 (m, 2H), 3.45-3.49 (m, 4H), 1.70 (m, 2H), 1.66-1.61 (m, 4H); 13C
NMR (126 MHz, CDCl3) δ = 152.58, 151.53, 141.16, 135.12, 128.64, 127.66,
126.64, 126.49, 121.38, 50.83, 42.76, 24.73; HRMS (ESI-TOF): [M + H]+
calculated for C18H21N2O+: 281.1648, found: 281.1657.
(S)-3,7-Dimethyloct-6-en-1-yl [1,1'-biphenyl]-4-ylcarbamate (2o)
Colorless solid (42.1 mg, 60%); mp 188-189 0C; 1H NMR (500 MHz, CDCl3) δ
= 7.57-7.53 (m, 4H), 7.46-7.40 (m, 4H), 7.31 (t, J = 7.5 Hz, 1H), 6.66 (s, 1H),
5.10 (t, J = 7.0 Hz, 1H), 4.25-4.19 (m, 2H), 2.04 (m, 2H), 1.73-1.71 (m, 1H),
1.68 (s, 3H), 1.51-1.49 (m, 3H), 1.38-1.39 (m, 1H), 1.26-1.25 (m, 1H), 1.24-
1.20 (m, 2H), 0.95 (d, J = 7.0 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ = 153.43,
140.50, 137.25, 136.21, 131.34, 128.71, 127.63, 126.94, 126.73, 124.52,
118.86, 63.85, 36.99, 35.76, 29.41, 25.69, 25.38, 19.38, 17.63; 97% ee was
determined by HPLC analysis [Daicel Chiralpak AD-H, Hexanes/Propanol =
98/2, 1.0 ml/min, λ = 254 nm, t (major) = 24.68 min, t(minor) = 26.25
min];HRMS (ESI-TOF): [M + H]+ calculated for C23H30NO2+: 352.2271, found:
352.2281.
N-([1,1'-Biphenyl]-4-yl)-3,5-dimethylpiperidine-1-carboxamide (3c)
Yellow solid (57.3 mg, 93%); mp 157-159 0C; 1H NMR (500 MHz, CDCl3) δ =
7.63-7.54 (m, 5H), 7.43 (t, J = 7.0 Hz, 2H), 7.31 (t, J = 7.5 Hz, 1H), 7.07 (d, J =
8.5 Hz, 2H), 4.52 (s, 1H), 3.40 (s, 1H), 2.60 (s, 1H), 2.34 (s, 1H), 1.87 (d, J =
13.0 Hz, 1H), 1.69 (s, 2H), 0.95 (d, J = 6.0 Hz, 6H), 0.83 (q, J = 12.0 Hz, 1H);
13C NMR (126 MHz, CDCl3) δ = 152.28, 151.53, 141.15, 135.11, 128.66,
127.65, 126.64, 126.52, 121.43, 56.94, 49.52, 42.55, 32.37, 30.68, 19.01;
HRMS (ESI-TOF): [M + H]+ calculated for C20H25N2O+: 309.1961, found:
309.1965.
Methyl (4-chlorophenyl)carbamate (2p)
Orange solid (33.3 mg, 90%); 1H NMR (500 MHz, DMSO-D6) δ = 9.79 (s,
1H), 7,48 (d, J = 9.0 Hz, 2H), 7.33 (t, J = 2.0 Hz, 2H), 3.67 (s, 3H); 13C NMR
(126 MHz, DMSO-D6) δ = 154.42, 138.67, 139.13, 136.48, 120.11, 52.24;
HRMS (ESI-TOF): [M + H]+ calculated for C8H9ClNO2+: 186.0316, found:
186.0322. Spectral data match those previously reported.[18]
N-([1,1'-Biphenyl]-4-yl)morpholine-4-carboxamide (3d)
Yellow solid (52.5 mg, 93%); mp 157-158 0C; 1H NMR (500 MHz, CDCl3) δ =
7.62 (d, J = 7.5 Hz, 2H), 7.56 (d, J = 7.5 Hz, 3H), 7.44 (t, J = 7.5 Hz, 2H), 7.32
(t, J = 7.5 Hz, 1H), 7.07 (d, J = 8.5 Hz, 2H), 3.73 (t, J = 5 Hz, 4H), 3.51 (s, 4H);
13C NMR (126 MHz, CDCl3) δ = 152.20, 150.84, 140.97, 135.62, 128.74,
127.73, 126.70, 126.67, 121.45, 66.65; HRMS (ESI-TOF): [M + H]+ calculated
for C17H19N2O2+: 283.1441, found: 283.1446.
Methyl (4-bromophenyl)carbamate (2q)
Colorless solid (41.7 mg, 91%); 1H NMR (500 MHz, DMSO-D6) δ = 9.79 (s,
1H), 7.46-7.41 (m, 4H), 3.66 (s, 3H); 13C NMR (126 MHz, DMSO-D6) δ =
154.39, 139.10, 132.03, 120.52, 114.41, 52.25; HRMS (ESI-TOF): [M + H]+
calculated for C8H9BrNO2+: 229.9811, found: 229.9817. Spectral data match
those previously reported.[18]
N-([1,1'-Biphenyl]-4-yl)pyrrolidine-1-carboxamide (3e)
Yellow liquid (49.5 mg, 93%); 1H NMR (600 MHz, CDCl3) δ = 7.79 (s, 1H),
7.58 (t, J = 8.4 Hz, 2H), 7.50-7.49 (m, 2H), 7.38 (t, J = 7.2 Hz, 2H), 7.26 (t, J =
7.2 Hz, 1H), 7.03 (t, J = 8.4 Hz, 2H), 3.48 (s, 4H), 1.90 (s, 4H); 13C NMR (151
MHz, CDCl3) δ = 150.85, 150.43, 141.19, 135.09, 128.71, 127.69, 126.67,
126.55, 121.57, 48.84, 45.36, 25.06; [M + H]+ calculated for C17H19N2O+:
267.1492, found: 267.1491.
Methyl (4-methoxyphenyl)carbamate (2r)
Colorless solid (16.3 mg, 45%); 1H NMR (500 MHz, CDCl3) δ = 7.26 (d, J =
5.0 Hz, 2H), 6.85- 6.83 (m, 2H), 6.57 (s, 1H), 3.77 (s, 3H), 3.74 (s, 3H); 13C
NMR (126 MHz, CDCl3) δ = 155.99, 154.51, 130.62, 120.66, 114.22, 55.47,
52.24; HRMS (ESI-TOF): [M + H]+ calculated for C9H12NO3+: 182.0812, found:
182.0817. Spectral data match those previously reported.[19]
1,1-Diallyl-3-(biphenyl-4-yl)urea (3f)
Yellow liquid (51.4 mg, 88%); 1H NMR (500 MHz, CDCl3) δ = 7.68 (s, 1H),
7.64-7.62 (m, 2H), 7.57-7.55 (m, 2H), 7.45 (t, J = 7.5 Hz, 2H), 7.33 (t, J = 6.0
Hz, 1H), 7.09 (d, J = 8.5 Hz, 2H), 5.88, (s, 2H), 5.25 (d, J = 8.5 Hz, 4H), 4.17
(s, 2 H), 3.85 (s, 2H); 13C NMR (126 MHz, CDCl3) δ = 152.55, 151.30, 141.13,
135.40, 133.87, 132.99, 128.68, 127.67, 126.68, 126.57, 121.53, 117.69,
Methyl naphthalen-1-ylcarbamate (2s)
Colorless solid (30.2 mg, 75%); mp 185-187 0C; 1H NMR (300 MHz, CDCl3)
δ = 7.91-7.88 (m, 3H), 7.70 (d, J = 8.4 Hz, 1H), 7.55-7.47 (m, 3H), 7.02 (s, 1H),
3.85 (s, 3H); 13C NMR (126 MHz, CDCl3) δ = 155.06, 134.12, 132.51, 128.75,
For internal use, please do not delete. Submitted_Manuscript
This article is protected by copyright. All rights reserved.